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A Case Report Discussing an Uncommon Peripheral Exudative Hemorrhagic
Chorioretinopathy
Abstract
Purpose: The purpose of this case report is to discuss an uncommon, unique hemorrhagic
chorioretinopathy. Method: A 79-year-old-white female presented to clinic with complaints of difficulty
reading at close distances and seeing faces at far distances in both eyes. An 85-year old white female
presented with no visual complaints but stated redness in the nasal corner of her right eye. This is a case
report of two patients that presented with geographic atrophy of the macula as well as midperipheral
RPE alterations in both eyes, which resembled intraretinal hemorrhages. Results: The ocular findings
associated with peripheral exudative hemorrhagic chorioretinopathy may include midperipheral intraretinal
hemorrhages, peripheral RPE mottling, subretinal fluid or hemorrhages, subretinal exudation, pigment
epithelial detachments, and/or vitreous hemorrhages. Conclusions: Although this condition is rare, primary
eye care providers should be aware of this unique clinical entity, its relationship to age-related macular
degeneration, and when these patients require a referral to a retinal specialist.
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ABSTRACT
Purpose: The purpose of this case report is to discuss an uncommon, unique hemorrhagic chorioretinopathy. Method: A 79-yearold-white female presented to clinic with complaints of difficulty reading at close distances and seeing faces at far distances in both
eyes. An 85-year old white female presented with no visual complaints but stated redness in the nasal corner of her right eye. This
is a case report of two patients that presented with geographic atrophy of the macula as well as midperipheral RPE alterations in
both eyes, which resembled intraretinal hemorrhages. Results: The ocular findings associated with peripheral exudative
hemorrhagic chorioretinopathy may include midperipheral intraretinal hemorrhages, peripheral RPE mottling, subretinal fluid or
hemorrhages, subretinal exudation, pigment epithelial detachments, and/or vitreous hemorrhages. Conclusions: Although this
condition is rare, primary eye care providers should be aware of this unique clinical entity, its relationship to age-related macular
degeneration, and when these patients require a referral to a retinal specialist.
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INTRODUCTION
Peripheral exudative hemorrhagic chorioretinopathy (PEHCR) is an uncommon bilateral peripheral retinal degeneration that affects
elderly patients. The clinical findings of PEHCR vary from peripheral retinal pigment epithelial mottling, subretinal fluid or
hemorrhages, subretinal exudation, pigment epithelial detachments to vitreous hemorrhages. Several conditions have been
mistaken for PEHCR, such as retinal capillary hemangioma, retinal macroaneurysm, retinal telangiectasia, choroidal detachment
and choroidal melanoma, with choroidal melanoma being the most common misdiagnosis for PEHCR. In 2005, Shields et al. found
that out of 12,000 patients referred with presumed uveal melanoma, 13% were found to have PEHCR. 1 We report two cases of
PEHCR with its unique presentation in patients that were examined in our clinic on two separate occasions.
CASE REPORT #1
A 79-year-old-white female presented with complaints of difficulty reading at close distances and seeing faces at far distances in
both eyes. She presented with best-corrected visual acuities of 20/80 OD and OS. Pupils were equal, round, and reactive to light,
with no afferent pupillary defect (APD). Confrontation visual fields were full to finger counting OD, OS, and the motility was full
range of motion OU. Slit lamp examination was remarkable for intraocular implants (PCIOL) OU. Dilated fundus examination (DFE)
of the right eye revealed macular geographic atrophy and a blot hemorrhage 1.5 DD superior to the optic nerve. DFE of the left
eye revealed macular geographic atrophy, and few dot-blot hemorrhages inferior to the optic nerve. Mid-peripheral retinal
evaluation of both eyes revealed various areas of RPE changes, which resembled intra-retinal hemorrhages. Peripheral retinal
evaluation of the right eye revealed a subretinal hemorrhage and a retinal scar due to a resolved subretinal hemorrhage. Peripheral
retina evaluation of the left eye revealed a scar due to a resolved subretinal hemorrhage. The patient was referred to a retinal
specialist for further evaluation, who confirmed the suspicion of peripheral exudative hemorrhagic chorioretinopathy (PEHCR) and
non-exudative age-related macular degeneration OU and recommended observation without treatment.

Figure 1. A digital photograph depicting multiple areas of mid-peripheral RPE alterations (blue arrows) suggestive of intraretinal
hemorrhages and an isolated peripheral subretinal hemorrhage superiorly (green arrow).
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Figure 2. Wide-field fundus photograph depicting geographic atrophy (blue arrow) as well as mid-peripheral and peripheral RPE
alterations (green arrow) suggestive of intraretinal hemorrhages temporally.
CASE REPORT #2
An 85-year old white female presented with complaints of redness in the nasal corner of her right eye. Her best-corrected visual
acuities were 20/70 OD and OS (she had no new visual complaints). Pupils were round and reactive to light OD, and fixed OS,
with no APD by reverse testing. Confrontation visual fields were full to finger counting OD and OS, and she demonstrated a full
range of ocular motion OU. Slit lamp examination was remarkable for corneal edema OS, and PCIOL OU. DFE of the right eye
and left eye revealed soft drusen and geographic atrophy OU. Mid-peripheral retinal evaluation of both eyes revealed
midperipheral RPE changes, which resembled intraretinal hemorrhages. Peripheral retinal evaluation of both eyes revealed RPE
pigmentary changes. The patient was referred to a retinal specialist for further evaluation, who confirmed the diagnosis of
peripheral exudative hemorrhagic chorioretinopathy (PEHCR) and non-exudative age-related macular degeneration OU.
Management consisted of observation alone.

© The Internet Journal of Allied health Sciences and Practice, 2021

UNCOMMON PERIPHERAL EXUDATIVE HEMORRHAGIC CHORIORETINOPATHY

3

Figure 3. A digital photograph of a patient with corneal edema depicting macular drusen (blue arrow) as well as mid-peripheral
RPE alterations (green arrows) suggestive of intraretinal hemorrhages superiorly, nasally, and temporally.
DISCUSSION
PEHCR is a rare degenerative disease of the peripheral retina predominantly seen in elderly women and accompanied by
hemorrhage and/or exudation.1,2Advanced age serves as a risk factor for development of PEHCR. Fluctuation of systemic blood
pressure and anticoagulant use are additional risk factors for hemorrhages and play a role in recurrent hemorrhages. 3 The clinical
features of PEHCR are described based on peripheral and macular pathology. In 2016, Cebeci et al reviewed retrospectively the
records of 12 elderly patients (21 eyes, 4 males and 8 females) diagnosed with PEHCR. They reported that 66.7% of the patients
were referred with a diagnosis of a choroidal mass. Seventy-five percent (75%) had bilateral involvement. Subretinal hemorrhages
and hemorrhagic/serous retinal pigment epithelial detachments were found in 71.4% of eyes, lipid exudation in 52.4%, chronic
RPE alterations in 23.8%, subretinal fibrosis is 9.5% and vitreous hemorrhage in 4.8%. Drusen accompanied the PEHC lesions in
52.4% of eyes, geographic atrophy was noted in 9.5%, and CNV scars in 9.5%.5
Due to their appearance as dark, elevated masses, PEHCR is often mistaken for choroidal melanoma. In 2009, Shields et al
reviewed retrospectively the records of 146 elderly patients (173 eyes, 67% female, 99% Caucasian). All were referred for possible
choroidal melanoma. The lesions were located temporally in 77% of eye, involved 1 or 2 quadrants in 92%, and were located
between the equator and ora serrata in 89%. Subretinal hemorrhage was found in 78% of eyes, retinal exudation in 21%, RPE
detachment in 28%, sub-RPE hemorrhage in 26%. Peripheral RPE alterations or drusen were found in 69% of ipsilateral and 42%
of contralateral eyes. Macular RPE alterations, drusen, or CVM were found in 48% of ipsilateral and 56% of contralateral eyes.
Lesion stability or regression was reported in 89% of eyes and progression in 11%. In addition, Shields et al. highlighted clinical
features that can be used to distinguish between PEHCR and choroidal masses. These include a more peripheral location of the
lesions in PEHCR, absence of sentinel vessels on anterior segment, retinal exudation, macular and peripheral RPE alterations,
appearance of hypofluorescence on fluorescein angiography (FA) and absence of intrinsic vascular pulsation and presence of a
clot retraction cleft on ultrasonography.2
Patients can be asymptomatic, otherwise they may complain of visual loss, floaters, photopsia, metamorphopsia, and
scotoma.3PEHCR lesions are commonly located in the temporal retina between the equator and the ora serrata. 2-5 Visual acuity in
PEHCR can be affected due to presence of vitreous hemorrhages, macular edema and/or accompanying AMD- related findings
such as drusen, choroidal neovascular membrane (CNV) and geographic atrophy. Shields et al. observed age-related macular
changes in 17% of ipsi- and 27% of contralateral eyes in PEHCR patients.2 PEHCR is diagnosed by patient history,
ophthalmoscopic findings and testing. Fundus fluorescein angiography findings include hypofluorescence consistent with
hemorrhage in the lesion area and irregular hyperfluorescence shown by CNV and homogenous hyperfluorescence typical of
serous PED in the periphery. Indocyanine green angiography can show polypoid formations and abnormal choroidal
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vasculature.4Usually, PECHR remains stable or regresses spontaneously, which can result in atrophy, fibrosis, or hyperplasia.5The
treatment options for PEHCR include the following: monitoring, vitrectomy, intravitreal anti-VEGF therapy, cryotherapy, laser
photocoagulation, or photodynamic therapy (PDT).6,7
The prognosis of PEHCR depends on the location of the lesion. In cases where the central vision or macula remain unaffected,
observation without intervention is recommended as the disease may spontaneously regress. 8Laser photocoagulation or PDT are
reserved for cases that are threatening the macula and for peripheral polyps. 9 A pars plana vitrectomy is recommended in rare
cases where vitreous hemorrhage or massive subretinal hemorrhage are present. 10 Choroidal neovascular membranes in the
periphery generally have a good prognosis, because they can be safely treated with laser therapy without the risk of central vision
loss.11
Conclusion
PEHCR is an uncommon, peripheral retinal degeneration that primarily affects elderly patients. Ocular findings may include
midperipheral RPE alterations, which resemble intraretinal hemorrhages, peripheral RPE mottling, subretinal fluid or hemorrhages,
subretinal exudation, pigment epithelial detachments, and/or vitreous hemorrhages. Although this condition is rare, primary eye
care providers should be aware of this unique clinical entity, its relationship to age-related macular degeneration, and that if there
is macular involvement or a rapidly progressive lesion, a referral to a retinal specialist is warranted.
A part of this manuscript has been used in a poster presentation at the 2018 and 2019 SECO Congress.
References
1. Shields, Jerry A., et al. "Pseudomelanomas of the posterior uveal tract: the 2006 Taylor R. Smith Lecture." Retina 25.6
(2005): 767-7
2. Shields, Carol L., et al. "Peripheral exudative hemorrhagic chorioretinopathy simulating choroidal melanoma in 173
eyes." Ophthalmology 116.3 (2009): 529-535.
3. Mantel, Irmela, Ann Schalenbourg, and Leonidas Zografos. "Peripheral exudative hemorrhagic chorioretinopathy:
polypoidal choroidal vasculopathy and hemodynamic modifications." American journal of ophthalmology 153.5 (2012):
910-922.
4. Annesley Jr, William H. "Peripheral exudative hemorrhagic chorioretinopathy." Transactions of the American
Ophthalmological Society 78 (1980): 321.
5. Cebeci, Zafer, et al. "Clinical features and course of patients with peripheral exudative hemorrhagic chorioretinopathy."
Turkish journal of ophthalmology 46.5 (2016): 215.
6. Mantel, Irmela, Sylvie Uffer, and Leonidas Zografos. "Peripheral exudative hemorrhagic chorioretinopathy: a clinical,
angiographic, and histologic study." American journal of ophthalmology 148.6 (2009): 932-938.
7. Alforja, María Socorro, et al. "Intravitreal bevacizumab injection for peripheral exudative hemorrhagic
chorioretinopathy." Japanese journal of ophthalmology 55.4 (2011): 425-427.
8. Pinarci, E. Y., et al. "Clinical characteristics of peripheral exudative hemorrhagic chorioretinopathy and its response to
bevacizumab therapy." Eye 27.1 (2013): 111-112.
9. Reese, Algernon B., and Ira S. Jones. "Hematomas under the retinal pigment epithelium." American journal of
ophthalmology 53.6 (1962): 897-910.
10. Gomi, Fumi, and Yasuo Tano. "Polypoidal choroidal vasculopathy and treatments." Current opinion in ophthalmology
19.3 (2008): 208-212.
11. Takkar, Brijesh, et al. "Peripheral choroidal neovascular membrane in a case of peripheral exudative hemorrhagic
chorioretinopathy managed with combination therapy." International ophthalmology 37.2 (2017): 429-43.

© The Internet Journal of Allied health Sciences and Practice, 2021

